ConductScience.org, home

Paper39157201

TLR2 Derangements Likely Play a Significant Role in the Inflammatory Response and Thrombosis in Patients with Ph(-) Classical Myeloproliferative Neoplasm.

Wang JC and 10 others. Mediators Inflamm, 2024. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. TLR2 Derangements Likely Play a Significant Role in the Inflammatory Response and Thrombosis in Patients with Ph(-) Classical Myeloproliferative Neoplasm. Papers, record 39157201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39157201

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
TLR2 Derangements Likely Play a Significant Role in the Inflammatory Response and Thrombosis in Patients with Ph(-) Classical Myeloproliferative Neoplasm.
PubMed
Journal
Mediators Inflamm
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.17, provisional
iCite
Revised in PubMed
2024-08-20
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang JCJen Chinhttps://orcid.org/0000-0002-9623-6645
2Shi GGuanfang
3Chen CChi
4Wong CChing
5Gotlieb VVladimir
6Joseph GGardith
7Nair KVKiron V
8Boyapati LLakshmi
9Ladan EEnayati
10Symanowski JTJames T
11Sun LLishi

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Toll-Like Receptor 2Major topic
Myeloproliferative DisordersMajor topic
Reactive Oxygen SpeciesMajor topic
ThrombosisMajor topic
InflammationMajor topic
Janus Kinase 2Major topic
Humans
Male
Female
Middle Aged
Aged
Toll-Like Receptor 4
Philadelphia Chromosome
Calgranulin B
Adult

Source PubMed

Download CSV of topics

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112676820CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation.Circ Res2003https://conductscience.org/library/papers/12676820PubMed
223033268Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).Blood2012https://conductscience.org/library/papers/23033268PubMed
316115126Serum interleukin (IL)-1, IL-2, sIL-2Ra, IL-6 and thrombopoietin levels in patients with chronic myeloproliferative diseases.Br J Haematol2005https://conductscience.org/library/papers/16115126PubMed
434527000The Toll-Like Receptor 2 Ligand Pam2CSK4 Activates Platelet Nuclear Factor-κB and Bruton's Tyrosine Kinase Signaling to Promote Platelet-Endothelial Cell Interactions.Front Immunol2021https://conductscience.org/library/papers/34527000PubMed
531648311Response to meta-analysis of leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera.Blood Adv2019https://conductscience.org/library/papers/31648311PubMed
612697438Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules.Trends Immunol2003https://conductscience.org/library/papers/12697438PubMed
728428710CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma.World J Gastroenterol2017https://conductscience.org/library/papers/28428710PubMed
817105814Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera.Blood2007https://conductscience.org/library/papers/17105814PubMed
918689872RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis.Carcinogenesis2008https://conductscience.org/library/papers/18689872PubMed
1012579287Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.Oncol Rep2003https://conductscience.org/library/papers/12579287PubMed
1117359388Monocyte-derived dendritic cells from highly atopic individuals are not impaired in their pro-inflammatory response to toll-like receptor ligands.Clin Exp Allergy2007https://conductscience.org/library/papers/17359388PubMed
1225037629Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis.Blood2014https://conductscience.org/library/papers/25037629PubMed
1323071157Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis.Circ Res2013https://conductscience.org/library/papers/23071157PubMed
1423765228Toll-like receptor alterations in myelodysplastic syndrome.Leukemia2013https://conductscience.org/library/papers/23765228PubMed
1523174192Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?Leuk Res2013https://conductscience.org/library/papers/23174192PubMed
1626538833The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms.Mediators Inflamm2015https://conductscience.org/library/papers/26538833PubMed
1720655352Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis.Exp Hematol2010https://conductscience.org/library/papers/20655352PubMed
1833128580HMGB1: an important regulator of myeloid differentiation and acute myeloid leukemia as well as a promising therapeutic target.J Mol Med (Berl)2021https://conductscience.org/library/papers/33128580PubMed
1918809714Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein.J Exp Med2008https://conductscience.org/library/papers/18809714PubMed
2024085768JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemia.Blood2013https://conductscience.org/library/papers/24085768PubMed

See all 47 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn PapersSource
42941857TLR2 Signaling in Myeloproliferative Neoplasms: Pathophysiological Roles, Mutation-Dependent Heterogeneity, and the Differential Efficacy of Ruxolitinib.Int J Mol Sci2026https://conductscience.org/library/papers/42941857PubMed
41436639Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasms.Leukemia2026https://conductscience.org/library/papers/41436639PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
JAK23717PubTator's text mininghttps://conductscience.org/library/genes/3717NCBI Gene
S100A96280PubTator's text mininghttps://conductscience.org/library/genes/6280NCBI Gene
TLR27097PubTator's text mininghttps://conductscience.org/library/genes/7097NCBI Gene
TLR47099PubTator's text mininghttps://conductscience.org/library/genes/7099NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39157201

GET https://conductscience.org/api/papers/v1/39157201/references?page=2